from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1803c/PE_PGRS32

LFCtreatmentdescriptionclass of inhibitor

-0.055

Amikacinug/mL Amikacintranslation

-0.446

Cap5-10ug/mL Capreomycintranslation

0.406

Rox10-50 ug/mL Roxithromycintranslation

-0.806

SM2-5 ug/mL Streptomycintranslation

-0.469

Tet5-10 ug/mL Tetracyclinetranslation

-0.218

Rif0.2-5ug/mL Rifampicintranscription

0.084

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.157

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.111

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.144

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.029

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.961

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.634

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.310

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-2.307

Nigericin50 uM Nigericinrespiration

-0.009

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.087

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.074

menadione6-10 ug/mL Menadionerespiration

0.330

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.945

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.551

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.668

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.587

NRP_1Non-replicating persistence stage 1dosRassociated

-0.422

Amp0.2mg/mL AmpicillincellWall

-0.133

Cephalexin20-100 ug/mL CephalexincellWall

-0.805

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.171

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.062

EMB10-20 ug/mL EthambutolcellWall

-0.108

Eta12-40 ug/mL EthionamidecellWall

-0.821

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.467

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.895

BZA0.12 mg/mL BenzamidearomaticAmides

-0.414

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.600

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.443

H2O24 mM hydrogen peroxideDNAdamaging

-0.491

Levo10 ug/mL LevofloxacinDNAdamaging

0.673

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.823

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.674

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.135

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.640

Antimycin12.5-50 ug/mL Antimycin A?

-0.895

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.488

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.168

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.068

PA8240.2-2 ug/mL PA-824?

0.075

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.430

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.451

Verapamil50 uM Verapamil?

0.424

mercaptoethanol2 mM 2-Mercaptoethanol?

0.894

methoxatin10-20 ug/mL Methoxatin?